DCF — ADVENTHEALTH DELAND
Enterprise Value: $17.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$17.4M
Enterprise Value
$0.0M
PV of Cash Flows
$17.4M
PV of Terminal Value
$28.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $203.0M | $6.6M | 3.0% | $-2.4M | $-2.2M |
| Year 2 | $209.1M | $8.9M | 4.0% | $-0.9M | $-0.7M |
| Year 3 | $215.4M | $11.3M | 5.0% | $0.7M | $0.5M |
| Year 4 | $221.8M | $12.8M | 6.0% | $1.6M | $1.1M |
| Year 5 | $228.5M | $13.7M | 6.0% | $2.0M | $1.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $17.4M. Terminal value accounts for 100% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$197.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.02756297226989098
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5